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Abstract
Background: Studies regarding the association between prehypertension and the structual changes of left heart
are scanty. However, which type of the geometrical change of left heart is predominated one in prehypertension
and hypertension is controversial. It is therefore important to investigate geometrical and functional changes of left
heart in adults with prehypertension and hypertension because of their prognostic significance.
Methods: The study was based on a cross-sectional design, a total of 10547 participants were classified into
normotension group, prehypertension group and hypertension group. We analyzed clinical characteristics,
echocardiographic parameters and distribution of left ventricular (LV) geometrical patterns in different groups.
Results: Participants with prehypertension had higher values of most of echocardiographic parameters than those
with normotension. The prevalence of left ventricular hypertrophy(LVH) was statistically different among three
groups (P <0.001), and the rates of LVH in the three groups were 5.9, 8.6, 28.4 % by indexation to height2.7 and 4.9,
5.3, 19.3 % by indexation to BSA, respectively. The prevalence rates of eccentric hypertrophy, concentric remodeling
and concentric hypertrophy were 7.3 %, 5.3 % and 1.4 % in prehypertension group, and 17.8 %, 8.8 % and 10.6 % in
hypertension group. Logistic regression analysis showed that systolic blood pressure (SBP), diastolic blood pressure
(DBP) and mean artery pressure (MAP) were all independent risk factors for left cardiac structural changes, and
pulse pressure (PP) was independent risk factor for concentric and eccentric hypertrophy. Among four indices, DBP
levels with OR values of 1.192, 1.759 and 1.278 were the strongest indicator for concentric remodeling, concentric
hypertrophy and eccentric hypertrophy, respectively (P <0.001).
Conclusions: There exists LV geometrical change in adults with prehypertension and hypertension in rural Chinese
population, and the eccentric hypertrophy was the highest proportion of geometric alterations. SBP, DBP, MAP and
PP were all positively associated with left cardiac structural changes, and the association of DBP was the strongest.
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Background
The type of LV geometrical change is determined mainly
by the predominating type of stimulus to the myocar-
dium, volume overload or pressure overload in hyper-
tension [1]. Systolic and diastolic function of the left
ventricle can be significantly influenced by the geomet-
rical patterns which are also important in cardiovascular
prognosis [2]. Three types of the geometrical change of
the left ventricle include concentric remodeling, concen-
tric hypertrophy, and eccentric hypertrophy [3]. The
geometrical patterns vary from one patient to another,
however, which is predominated type in hypertension
and prehypertension is controversial. Prehypertension,
as a transition from the normal blood pressure (BP) to
the diagnosis of hypertension, is considered as a starting
point in the cardiovascular disease (CVD) [4], has grad-
ually attracted more attention in recent years. In 2003,
the United States JNC7 defined prehypertension as SBP
of 120–139 mmHg and (or) DBP of 80–89 mmHg [5].
Although persons do not have symptoms in prehyper-
tensive stage, some geometrical and functional changes
of the heart may be detected by echocardiography. Some
investigators had reported that hypertensive patients had
higher prevalence of geometrical and functional changes
in left heart [6–8], but data regarding the association be-
tween prehypertension and geometrical and functional
changes of left heart are scanty, especially in rural adults
from Northeast China, where hypertension is prevalent.
Therefore, we conducted this study to investigate geo-
metrical and functional changes of left heart in adults




Liaoning Province is located in Northeast China. From
January 2012 to August 2013, a representative sample
aged ≥ 35 years was selected to describe the prevalence,
incidence and natural history of cardiovascular risk fac-
tors in rural areas of Liaoning Province. The study
adopted a multi-stage, stratified randomly cluster-
sampling scheme. In the first stage, 3 counties (Dawa,
Zhangwu, and Liaoyang County) were selected from the
eastern, southern, and Northern region of Liaoning
province. In the second stage, one town was randomly
selected from each county (a total of 3 towns). In the
third stage, 8–10 rural villages from each town were ran-
domly selected (a total of 26 rural villages). Participants
with pregnancy, malignant tumor and mental disorder
were excluded. All the eligible permanent residents
aged ≥ 35 years from each village were invited to attend
the study (a total of 14016 participants). Of those, 11956
participants agreed and completed the present study and
the response rate was 85.3 %. The study was approved
by the Ethics Committee of China Medical University
(Shenyang, China). All procedures were performed in ac-
cordance with the ethical standards. Written consent
was obtained in all participants after they had been in-
formed of the objectives, benefits, medical items and
confidentiality agreement of personal information. If the
participants were illiterate, we obtained the written in-
formed consents from their proxies. In this report, sub-
jects were excluded if they met any of the following
criteria: congenital heart disease, cardiac tumor, myocar-
dial infarction, pericardia disease, cardiomyopathy or
other organic heart disease, all kinds of serious
arrhythmia, heart valve disease (the valve with moderate
to severe reflux or narrow). Finally, a total of 10547 par-
ticipants were available for analysis, 3616 subjects with
prehypertension, 5280 patients with hypertension and
1651 participants with normotension.
Blood pressure measurement
According to American Heart Association protocol, BP
was measured three times at 2 min intervals after at
least 5 min of rest using a standardized automatic elec-
tronic sphygmomanometer (HEM-907; Omron), which
had already been validated according to the British
Hypertension Society protocol [9]. The participants were
advised to avoid caffeinated beverages and exercise for at
least 30 min before the measurement. During the
measurement, participants were seated with the arm
supported at the level of the heart. The mean of three
BP measures were averaged for analysis. According to
the United States JNC7, PH was defined as SBP of
120–139 mmHg and (or) DBP of 80–89 mmHg.
Hypertension was diagnosed as a SBP ≥140 mmHg
and (or) a DBP ≥90 mmHg. Normotensive controls
had SBP <120 mmHg and DBP <80 mmHg. PP was
calculated by (SBP-DBP) and MAP was calculated by
1/3(SBP + 2DBP).
Echocardiography measurements
The echocardiograms were obtained using a commer-
cially available Doppler echocardiograph (Vivid, GE
Healthcare, United States), with a 3.0-MHz transducer.
The transthoracic echocardiogram included M-mode, 2-
dimensional, spectral and color Doppler with subjects in
the supine position. Echocardiogram analyses and read-
ings were performed by three physicians specialized in
echocardiography. The parasternal acoustic window was
used to record two-dimensional and M-mode images of
the LV internal diameter, wall thickness, aortic root and
left atrium. The apical acoustic window was used to rec-
ord 4- and 5-chamber images.
Correct orientation of planes for imaging and Doppler
recordings was verified using previously described pro-
cedures [10]. All M-mode tracings were obtained at
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50 mm/s. LV end-diastolic internal dimension (LVIDd),
LV end-systolic internal dimension (LVIDs), interventric-
ular septal thickness (IVSd), posterior wall thickness
(PWTd) and left atrial diameter (LAD), as well as aortic
annular diameter (AOD) were performed according to
the guidelines of the American Society of Echocardiog-
raphy and the European Association of Echocardiog-
raphy [11, 12].
Left ventricular mass (LVM) was estimated by Devereux’
s formula according to the American Society of Echocar-
diography simplified cubed equation [13]. LVM=
0.8 × [1.04{(IVSTd + PWTd + LVIDd)3–LVIDd3}] + 0.6 g.
LVM was divided by height2.7 and body surface area
(BSA) to obtain left ventricular mass index (LVMIht2.7
and LVMIBSA). LVH was diagnosed using the following
defining criteria [14, 15]: >48 g/m2.7 and 44 g/m2.7 for
men and women respectively when LVM was indexed to
height2.7, and >115 g/ m2 and >95 g/ m2 for men and
women respectively when LVM was indexed to BSA.
The relative wall thickness (RWT) was calculated using
the formula (IVSd + PWTd) / LVIDd. Increased RWT
was present when this ratio was >0.42 [16].
LV geometry was classified into four patterns using
LVMIht2.7 and RWT values [8, 14]. These are normal
geometry when LVMI was normal and RWT ≤ 0.42, con-
centric remodeling when LVMI was normal and RWT >
0.42, concentric hypertophy when LVMI was increased
and RWT > 0.42, eccentric hypertrophy when LVMI was
increased and RWT ≤ 0.42. The LV end-diastolic volu-
me(LVEDV) and LV end-systolic volume(LVESV) were
determined using the Teichholz equations [17]:
LVEDV(ml) = LVIDd3 × 7.0/(2.4 + LVIDd), LVESV(ml) =
LVIDs3 × 7.0/(2.4 + LVIDs). Using LVEDV and LVESV,
the LV ejection fraction (EF) was calculated as [(LVEDV-
LVESV)/LVEDV] × 100 % and LV fractional shortening
(FS) was calculated as [(LVIDd-LVIDs)/LVIDd] × 100 %.
All Doppler echocardiographic recordings were regis-
tered with 100 mm/s and performed in expiration. Ex-
aminations of mitral inflow were performed by pulsed
wave Doppler with the sample volume at the mitral valve
leaflet tips in the apical four-chamber view and early
transmitral diastolic peak flow (E) and atrial peak flow
(A) and E/A ratio were determined [16]. Diastolic dys-
function was defined as E/A <1. The individuals who
presented pseudonormalization, defined as E/A at least
one in conjunction with end-systolic LAD, in parasternal
long axis view, more than 3.8 cm for women and 4.0 cm
for men, were also considered as having diastolic dys-
function [18].
Covariate measurements and definitions
Information on covariates, such as age, gender and life-
style, were collected during a single clinic visit by cardiolo-
gists and trained nurses using a standard questionnaire by
face-to-face interview. Before the survey was performed,
we invited all eligible investigators to attend the organized
training. The training contents included the purpose
of this study, how to administer the questionnaire,
the standard method of measurement, the importance
of standardization, and the study procedures. A strict
test was evaluated after this training, only those who
scored perfectly on the test could become investiga-
tors. During data collection, our inspectors had fur-
ther instructions and support.
Weight and height were measured to the nearest
0.1 kg and 0.1 cm respectively with the participants in
light weight clothing and without shoes. Waist circum-
ference (WC) was measured at the umbilicus using a
non-elastic tape (to the nearest 0.1 cm), with the partici-
pants standing at the end of normal expiration. Body
mass index (BMI) was calculated as weight in kilograms
divided by the square of the height in meters. BSA was
calculated as [0.0061 × height (cm) + 0.0128 × weight
(kg)-0.1529].
Fasting blood samples were collected in the morning
after at least 12 h of fasting for all participants. Blood
samples were obtained from an antecubital vein into
Vacutainer tubes containing EDTA. Fasting plasma glu-
cose (FPG), total cholesterol (TC), low-density lipopro-
tein cholesterol (LDL-C), high-density lipoprotein
cholesterol (HDL-C), triglyceride (TG), plasma creatine
(PC), uric acid (UA) and other routine blood biochem-
ical indexes were analyzed enzymatically on an autoana-
lyzer. All laboratory equipment was calibrated and
blinded duplicate samples were used.
Statistical analysis
Continuous variables were presented as the means and
standard deviation (SD), and categorical variables were
expressed as numbers or percentages. Differences among
categories were evaluated using ANOVA, non-parametric
test or the χ2-test as appropriate. Multivariate logistic re-
gression analyses were used to identify independent fac-
tors of SBP, DBP, MAP, and PP with odds ratios (ORs) and
corresponding 95 % confidence intervals (CIs) calculated.
All the statistical analyses were performed using SPSS ver-




As shown in Table 1, of the 10547 participants, 54.2 %
participants were women, 5280 (50.1 %) and 3616
(34.3 %) met JNC-7 criteria for prehypertension and
hypertension, respectively. Compared with the normo-
tension group, hypertension and prehypertension groups
were more likely to have higher weight, WC, BSA and
BMI. Both the hypertension and prehypertension groups
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had higher SBP, DBP, MAP, PP, TG, TC, LDL-C, FPG,
hemoglobin and UA than the normotension group. The
hypertension group had significantly higher PC, but it
did not differ statistically between prehypertension and
normotension group.
Echocardiographic parameters comparison
Compared with the normotension group, LVIDd, LVIDs,
LVM, LVMI, AOD, LAD, LAD/BSA, A wave, LVEDV,
LVESV and SV were significantly higher, while E wave
and E/A were significantly lower in prehypertension
group (P <0.05). Among the three subgroups, hyperten-
sion group had the highest IVSd, PWTd, LVIDd, LVIDs,
LVM, LVMI, RWT, AOD, LAD, LAD/BSA, A wave,
LVEDV, LVESV and SV, and the lowest E wave, E/A,
LVEF and FS (P <0.001). The prevalence of LVH was sta-
tistically different among three groups (P < 0.001), and
the rates of LVH in the three groups were 5.9, 8.6,
28.4 % by indexation to height2.7 and 4.9, 5.3, 19.3 % by
indexation to BSA, respectively (Table 2).
Distribution of LV geometrical pattern
Classification of LV geometry showed that the eccentric
hypertrophy was the highest proportion of geometric al-
terations in hypertension and prehypertension groups.in
the present study population. The prevalence rates of ec-
centric hypertrophy, concentric remodeling and concen-
tric hypertrophy were 7.3 %, 5.3 % and 1.4 % in
prehypertension group, and 17.8 %, 8.8 % and 10.6 % in
hypertension group (Table 3).
Association of BP indices with left heart remodeling in
prehypertension and hypertension group
After adjustment for age, gender, race, height, weight,
WC, heart rate, smoking, drinking, salt, degree of phys-
ical labor and education, TG, TC, HDL-C, LDL-C, FPG,
Table 1 Baseline characteristics for normotension, prehypertension and hypertension
Variables NT PH HT
N = 1651 N = 3616 N = 5280
Age 48.4 ± 9.0 50.9 ± 9.7* 57.1 ± 10.1#†
Males, n (%) 544 (32.9) 1728 (47.8) 2553 (48.4)
Han ethnicity, n (%) 1575 3428 5014
Height, cm 160.1 ± 7.5 161.3 ± 8.2* 160.2 ± 8.4#
Weight, kg 59.5 ± 9.6 63.6 ± 11.1* 65.8 ± 11.5#†
WC, cm 77.7 ± 8.6 80.9 ± 9.3* 84.8 ± 9.7#†
BSA, m2 1.59 ± 0.15 1.64 ± 0.18* 1.67 ± 0.18#†
BMI, kg/ m2 23.2 ± 3.3 24.4 ± 3.5* 25.6 ± 3.6#†
BMI≥ 30 kg/ m2, n (%) 2.4 5.9 10.5**
Current smoke, n (%) 32.6 36.6 34.7**
Current drinking, n (%) 12.6 23.8 24.5**
Heart rate, bmp 76 ± 11 77 ± 12* 79 ± 14#†
SBP, mmHg 112.1 ± 5.8 129.2 ± 5.8* 158.7 ± 19.3#†
DBP, mmHg 69.1 ± 5.8 77.7 ± 6.4* 88.8 ± 11.0#†
MAP, mmHg 83.5 ± 5.1 94.8 ± 5.1* 112.1 ± 11.7#†
PP, mmHg 43.0 ± 5.8 51.6 ± 7.4* 69.9 ± 17.4#†
TC, mmol/L 4.9 ± 1.0 5.1 ± 1.0* 5.4 ± 1.1#†
TG, mmol/L 1.3 ± 1.1 1.5 ± 1.3* 1.8 ± 1.6#†
LDL-C, mmol/L 2.6 ± 0.7 2.8 ± 0.8* 3.1 ± 0.9#†
HDL-C, mmol/L 1.4 ± 0.3 1.4 ± 0.4* 1.4 ± 0.4†
FPG, mmol/L 5.5 ± 1.2 5.7 ± 1.3* 6.2 ± 1.9#†
PC, mg/dl 70.1 ± 11.6 71.2 ± 12.8 72.9 ± 27.3#†
Hemoglobin, g/dl 132.8 ± 17.2 138.6 ± 20.0* 140.6 ± 18.1#†
UA, umol/L 270.7 ± 77.2 285.2 ± 81.3* 301.0 ± 87.2#†
Antihypertensive medication, n (%) 0 0 1525 (28.9)
NT indicates normotension; PH, prehypertension; HT, hypertension
*P < 0.001 between PH and NT, #P < 0.001 between HT and PH, †P < 0.001 between HT and NT, ** P < 0.001 among three groups
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PC, hemoglobin and UA and antihypertensive medica-
tion, logistic regression models were performed to esti-
mate the relationship of four BP indices with LV
remodeling in prehypertension and hypertension groups.
Results showed that SBP, DBP and MAP were all inde-
pendent risk factors for left cardiac structural changes,
and PP was independent risk factor for concentric and
eccentric hypertrophy. Among four BP indices, DBP was
the strongest indicator for LV remodeling (Table 4).
Discussion
Our research showed that LV remodeling was found in
prehypertension group. Although there were no signifi-
cantly differences in IVSd, PWTd, RWT between prehy-
pertension and normotension group, the values of LVIDd,
LVIDs, LVMI, LVEDV, LVESV and SV that reflect ven-
tricular volume indexes were significantly higher in prehy-
pertension group than normotension group, which
suggested that there existed cardiac enlargement, LV re-
modeling and increased LV volume in prehypertensive sta-
tus. However, hypertension can produce more obvious
myocardial cell compensatory enlargement, LV hyper-
trophy, LV remodeling and volume increases [19]. The
prevalence of LVH was statistically different among three
groups and the rates of LVH were higher when LVM was
indexed to height2.7 than to BSA in our study. BSA has
been widely used to normalize LVM, however, this does
not correctly identify pathological LV hypertrophy in all
people, especially when body composition is altered, or in
different ethnic groups and may not account for the re-
sultant variation in LVM. Indexation by height2.7 may be
considered a more suitable approach to scaling LVM for
body size in recent years, especially in obese and over-
weight hypertensive patients, to some extent independ-
ently from the cut-off settled. Considering the presence of
Table 2 Echocardiographic parameters comparison of
normotension, prehypertension and hypertension
Variables NT PH HT
N = 1651 N = 3616 N = 5280
IVSd, cm 0.83 ± 0.18 0.84 ± 0.12 0.93 ± 0.29#†
LVIDd, cm 4.56 ± 0.37 4.68 ± 0.40* 4.76 ± 0.43#†
LVIDs, cm 3.0 ± 0.37 3.08 ± 0.40& 3.15 ± 0.43#†
PWTd, cm 0.83 ± 0.22 0.84 ± 0.30 0.89 ± 0.22#†
LVM, g 122.7 ± 65.8 133.6 ± 74.5* 153.1 ± 103#†
LVMIht2.7, g/m
2.7 34.5 ± 19.1 36.8 ± 20.7* 42.9 ± 27.7#†
LVMIBSA, g/m
2 77.4 ± 41.2 81.3 ± 44.9* 91.7 ± 59.5#†
RWT 0.36 ± 0.07 0.36 ± 0.08 0.38 ± 0.09#†
LVH, height2.7, n (%) 97 (5.9) 272 (8.6) 1500 (28.4)**
LVH, BSA, n (%) 81 (4.9) 192 (5.3) 1019 (19.3)**
AOD, cm 2.16 ± 0.25 2.22 ± 0.31* 2.28 ± 0.30#†
LAD, cm 3.20 ± 0.35 3.31 ± 0.37* 3.45 ± 0.40#†
LAD/BSA, cm/ m2 2.03 ± 0.23 2.03 ± 0.24* 2.08 ± 0.26#†
E wave, cm/s 76.6 ± 19.0 75.0 ± 19.4& 70.1 ± 18.8#†
A wave, cm/s 67.5 ± 15.2 72.0 ± 15.8* 81.2 ± 17.7#†
E/A 1.19 ± 0.38 1.09 ± 0.37* 0.91 ± 0.34#†
LVEDV, ml 96.3 ± 18.3 102.5 ± 21.0* 106.6 ± 22.8#†
LVESV, ml 35.7 ± 10.7 38.4 ± 12.3& 40.7 ± 13.6#†
SV, ml 60.6 ± 14.8 64.1 ± 17.8& 65.9 ± 19.2#†
LVEF, % 62.82 ± 8.88 62.41 ± 9.87 61.67 ± 10.33#†
FS, % 34.27 ± 6.46 34.14 ± 7.13 33.68 ± 7.39#†
*P < 0.001 between PH and NT, &P < 0.05 between PH and NT, #P < 0.001
between HT and PH, †P < 0.001 between HT and NT, ** P < 0.001 among
three groups
Table 3 Classification of LV geometry according to gender and BP groups
Classification NT PH HT P
(N = 1651) (N = 3616) (N = 5280)
Normal geometry, n (%) 1447 (87.6) 3312 (86.1) 3314 (62.8) <0.001
male 498 (34.4) 1544 (49.6) 1758 (53.0)
female 949 (65.6) 1568 (50.4) 1556 (47.0)
Concentric remodeling, n (%) 106 (6.4) 192 (5.3) 464 (8.8) <0.001
male 28 (26.4) 70 (36.5) 222 (47.8)
female 78 (73.6) 122 (63.5) 242 (52.2)
Concentric hypertrophy, n (%) 13 (0.8) 49 (1.4) 561 (10.6) <0.001
male 4 (30.8) 21 (42.9) 241 (43.0)
female 9 (69.2) 28 (57.1) 320 (57.0)
Eccentric hypertrophy, n (%) 85 (5.1) 263 (7.3) 941 (17.8) <0.001
male 14 (16.5) 93 (35.4) 332 (35.3)
female 71 (83.5) 170 (64.6) 609 (64.7)
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a significative difference in BMI between the three groups
in our study, we indexed LVM by height2.7 to classify LV
geometry in order to minimize the interference of obesity
[19–21]. Impaired LV diastolic dysfunction happened earl-
ier than systolic dysfunction and was followed by a de-
crease in early-diastolic ventricular filling and a greater
atrial contribution to ventricular filling in the late-systolic
period [22]. Our study showed that hypertension and pre-
hypertension groups had lower E wave and E/A, but
higher A wave. No significant differences in contractility
indexes between normotension and prehypertension
groups indicated that myocardial total systolic function
had not yet been compromised despite LV geometric
abnormalities at the stage of prehypertension. LAD, as
evidence of diastolic dysfunction, was significantly
progressive enlargement from prehypertension to hyper-
tension group.
According to LV hemodynamic changes, LV geometrical
change can be classified into three types: concentric re-
modeling, concentric hypertrophy and eccentric hyper-
trophy. This is determined to a large extent by whether
pressure or volume overload is predominating. Approxi-
mately 7.3 % of prehypertensive participants and 17.8 % of
hypertensive ones in our study had eccentric hypertrophy
which was the highest proportion of abnormal geometrical
changes in the our study population. On the one hand,
the high prevalence of eccentric hypertrophy may be re-
lated to the status of volume overload which play a key
role in LV adaptations in hypertension or the high preva-
lence of obesity [23–25]. On the other hand, subjects in
hypertension and prehypertension groups with eccentric
geometry are more likely to have coronary artery disease
than patients with concentric geometry [26]. Previous
studies had indicated that coronary flow reserve was obvi-
ously impaired in patients with prehypertension and
hypertension, and may occur in the early stage before ap-
parent hypertrophy, which may cause subsequent ische-
mia, as a consequence of postischemic remodeling [27].
Consistent with our results, some other studies had also
showed the similar results that eccentric hypertrophy was
the most frequent pathological pattern of LV remodeling
[28–30]. However, some studies also reported that con-
centric remodeling and concentric hypertrophy were the
predominant among their studied population with hyper-
tension [31–34]. The difference can partly be explained by
difference in echocardiographic cut-off values for defining
LVH and the heterogeneity of different population [8]. Be-
sides, our study showed that participants with LV geomet-
rical changes were more likely to be females. It suggested
that the women’s hearts were more susceptible to trophic
stimuli and neurohumoral factors which may be associ-
ated with LV gender-dependent response effect [35, 36].
Eccentric and concentric remodeling were associated with
increased weight, BMI, and WC. So in our study, some
participants with normotension had LV remodeling. How-
ever, LV remodeling was as expected more frequent in the
persons suffering from prehypertension or hypertension.
Results from multivariate logistic regression analysis
showed that SBP, DBP, MAP and PP were all positively
associated with left cardiac structural changes. DBP was
the strongest risk factor for concentric remodeling, con-
centric hypertrophy and eccentric hypertrophy. Thus, it
reminds us to strengthen the control of hypertension
and pay more attention to prehypertensive status, in
order to delay the cardiac damage and the onset of heart
failure [37].
This study has some limitations. First, our data is a re-
ferral and not a general adult population throughout
China. Second, although we made extensive efforts to
standardize measurements using the same echocardio-
graphic criteria, subtle differences in performance tech-
nique among doctors could still influenced results. In
addition, our results were based on a cross-sectional de-
sign, thus we are unable to assess the duration of hyper-
tension and antihypertensive medication exactly.
Conclusions
In this study, there existed LV remodeling and geomet-
rical change in prehypertensive status, and more obvious
myocardial cell compensatory enlargement, LV hyper-
trophy, LV remodeling and volume increases in adults
with hypertension in rural Chinese population. The
prevalence of LVH was statistically different among three
groups and the rates of LVH were higher when LVM
was indexed to height2.7 than to BSA. The eccentric
hypertrophy was the commonest abnormal geometrical
Table 4 Multiple logistic regression analysis of BP for left heart remodeling in prehypertension and hypertension goups
Classification Concentric remodeling Concentric hypertrophy Eccentric hypertrophy
OR (95 % CI) P OR (95 % CI) P OR (95 % CI) P
SBP,(+10 mmHg) 1.065 (1.022–1.110) 0.003 1.358 (1.304–1.414) <0.001 1.159 (1.112–1.198) <0.001
DBP,(+10 mmHg) 1.192 (1.102–1.290) <0.001 1.759 (1.623–1.908) <0.001 1.278 (1.197–1.363) <0.001
MAP,(+10 mmHg) 1.148 (1.075–1.226) <0.001 1.700 (1.591–1.817) <0.001 1.277 (1.211–1.348) <0.001
PP, (+10 mmHg) 1.025 (0.971–1.082) 0.364 1.314 (1.247–1.384) <0.001 1.149 (1.101–1.200) <0.001
Adjustment for age, gender, race, height, weight, WC, heart rate, smoking, drinking, salt, degree of physical labor and education, TG, TC, HDL-C, LDL-C, FPG, PC,
hemoglobin, UA and antihypertensive medication
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pattern in our study and LV geometrical changes were
more likely to be females. SBP, DBP, MAP and PP were
all positively associated with left cardiac structural
changes, and the association of DBP was the strongest.
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